1. Home
  2. PFG vs NTRA Comparison

PFG vs NTRA Comparison

Compare PFG & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFG
  • NTRA
  • Stock Information
  • Founded
  • PFG 1879
  • NTRA 2003
  • Country
  • PFG United States
  • NTRA United States
  • Employees
  • PFG N/A
  • NTRA N/A
  • Industry
  • PFG Specialty Insurers
  • NTRA Medical Specialities
  • Sector
  • PFG Finance
  • NTRA Health Care
  • Exchange
  • PFG Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • PFG 19.9B
  • NTRA 20.6B
  • IPO Year
  • PFG N/A
  • NTRA 2015
  • Fundamental
  • Price
  • PFG $77.73
  • NTRA $162.22
  • Analyst Decision
  • PFG Hold
  • NTRA Strong Buy
  • Analyst Count
  • PFG 14
  • NTRA 15
  • Target Price
  • PFG $84.07
  • NTRA $152.67
  • AVG Volume (30 Days)
  • PFG 1.2M
  • NTRA 1.2M
  • Earning Date
  • PFG 02-10-2025
  • NTRA 11-12-2024
  • Dividend Yield
  • PFG 3.78%
  • NTRA N/A
  • EPS Growth
  • PFG N/A
  • NTRA N/A
  • EPS
  • PFG N/A
  • NTRA N/A
  • Revenue
  • PFG $14,066,500,000.00
  • NTRA $1,531,955,000.00
  • Revenue This Year
  • PFG N/A
  • NTRA $53.06
  • Revenue Next Year
  • PFG $5.79
  • NTRA $11.04
  • P/E Ratio
  • PFG N/A
  • NTRA N/A
  • Revenue Growth
  • PFG N/A
  • NTRA 54.94
  • 52 Week Low
  • PFG $72.21
  • NTRA $57.22
  • 52 Week High
  • PFG $91.98
  • NTRA $175.63
  • Technical
  • Relative Strength Index (RSI)
  • PFG 27.01
  • NTRA 59.07
  • Support Level
  • PFG $77.17
  • NTRA $164.66
  • Resistance Level
  • PFG $84.69
  • NTRA $172.80
  • Average True Range (ATR)
  • PFG 1.26
  • NTRA 5.07
  • MACD
  • PFG -0.69
  • NTRA -1.63
  • Stochastic Oscillator
  • PFG 7.10
  • NTRA 30.25

About PFG Principal Financial Group Inc

Principal Financial Group Inc is a leader in Global investment management offering businesses, individuals and institutional clients a wide range of financial products and services, including retirement, asset management and insurance through diverse family of financial services companies. It operates in four business segments that are Retirement and Income Solutions, Principal Global Investors, Principal International, and United States Insurance Solutions. The company receives maximum revenue in the form of premiums.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: